Long-term prevention of chronic allograft rejection by regulatory T-cell immunotherapy involves host Foxp3-expressing T cells

Blood

Volumn 121, Issue 21, 2013, Pages 4303-4310

  Pasquet, Lise ^a,b,c   Douet, Jean Yves ^a,b,c   Sparwasser, Tim ^d   Romagnoli, Paola ^a,b,c   Van Meerwijk, Joost P M ^a,b,c  

^a INSERM   (France)

^b CNRS   (France)

^c UNIVERSITÉ PAUL SABATIER   (France)

^d INSTITUTE OF INFECTION IMMUNOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DIPHTHERIA TOXIN; TRANSCRIPTION FACTOR FOXP3; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, MOUSE;

ALLOGRAFT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW TRANSPLANTATION; CHIMERA; CHRONIC ALLOGRAFT REJECTION; CHRONIC GRAFT REJECTION; CONTROLLED STUDY; DONOR; HEART TRANSPLANTATION; HOST; IMMUNOTHERAPY; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SKIN ALLOGRAFT; ALLOTRANSPLANTATION; ANIMAL; C57BL MOUSE; CELL CULTURE; CHRONIC DISEASE; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HISTOCOMPATIBILITY; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; MALE; METABOLISM; METHODOLOGY; SKIN TRANSPLANTATION; TIME; TRANSPLANTATION;

ANIMALS; BONE MARROW TRANSPLANTATION; CELLS, CULTURED; CHRONIC DISEASE; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; GRAFT REJECTION; GRAFT SURVIVAL; IMMUNE TOLERANCE; IMMUNOTHERAPY; MALE; MICE; MICE, INBRED C57BL; SKIN TRANSPLANTATION; T-LYMPHOCYTES, REGULATORY; TIME; TRANSPLANTATION CHIMERA; TRANSPLANTATION, HOMOLOGOUS;

MLCS; MLOWN;

EID: 84880424523     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2012-08-452037     Document Type: Article

References (41)

1. Kahan BD. Individuality: the barrier to optimal immunosuppression. Nat Rev Immunol. 2003; 3(10):831-838.
2. Meier-Kriesche HU, Kaplan B. The search for CNI-free immunosuppression: no free lunch. Am J Transplant. 2011;11(7):1355-1356.
3. Hogquist KA, Baldwin TA, Jameson SC. Central tolerance: learning self-control in the thymus. Nat Rev Immunol. 2005;5(10):772-782.
4. Waldmann H. Tolerance: an overview and perspectives. Nat Rev Nephrol. 2010;6(10): 569-576.
5. Capone M, Romagnoli P, Beermann F, MacDonald HR, van Meerwijk JPM. Dissociation of thymic positive and negative selection in transgenic mice expressing major histocompatibility complex class I molecules exclusively on thymic cortical epithelial cells. Blood. 2001;97(5):1336-1342.
6. Hudrisier D, Feau S, Bonnet V, Romagnoli P, van Meerwijk JPM. In vivo maintenance of T-lymphocyte unresponsiveness induced by thymic medullary epithelium requires antigen presentation by radioresistant cells. Immunology. 2003;108(1):24-31.
7. Laufer TM, DeKoning J, Markowitz JS, Lo D, Glimcher LH. Unopposed positive selection and autoreactivity in mice expressing class II MHC only on thymic cortex. Nature. 1996;383(6595): 81-85.
8. Laufer TM, Fan L, Glimcher LH. Self-reactive T cells selected on thymic cortical epithelium are polyclonal and are pathogenic in vivo. J Immunol. 1999;162(9):5078-5084.
9. van Meerwijk JPM, Marguerat S, Lees RK, Germain RN, Fowlkes BJ, MacDonald HR. Quantitative impact of thymic clonal deletion on the T cell repertoire. J Exp Med. 1997;185(3): 377-383.
10. Bouneaud C, Kourilsky P, Bousso P. Impact of negative selection on the T cell repertoire reactive to a self-peptide: a large fraction of T cell clones escapes clonal deletion. Immunity. 2000;13(6): 829-840.
11. Sakaguchi S, Miyara M, Costantino CM, Hafler DA. FOXP31 regulatory T cells in the human immune system. Nat Rev Immunol. 2010;10(7): 490-500.
12. Josefowicz SZ, Lu LF, Rudensky AY. Regulatory T cells: mechanisms of differentiation and function. Annu Rev Immunol. 2012;30:531-564.
13. Shevach EM. Biological functions of regulatory T cells. Adv Immunol. 2011;112:137-176.
14. Billingham RE, Lampkin GH, Medawar PB, Williams HLL. Tolerance to homografts, twin diagnosis, and the freemartin condition in cattle. Heredity. 1952;6:201-212.
15. Pasquet L, Joffre O, Santolaria T, van Meerwijk JPM. Hematopoietic chimerism and transplantation tolerance: a role for regulatory T cells. Front Immunol. 2011;2:80.
16. Joffre O, Gorsse N, Romagnoli P, Hudrisier D, van Meerwijk JPM. Induction of antigen-specific tolerance to bone marrow allografts with CD41 CD251 T lymphocytes. Blood. 2004;103(11): 4216-4221.
17. Joffre O, van Meerwijk JPM. CD41CD251 regulatory T lymphocytes in bone marrow transplantation. Semin Immunol. 2006;18(2): 128-135.
18. Joffre O, Santolaria T, Calise D, Al Saati T, Hudrisier D, Romagnoli P, van Meerwijk JPM. Prevention of acute and chronic allograft rejection with CD41CD251Foxp31 regulatory T lymphocytes. Nat Med. 2008;14(1):88-92.
19. Tsang JY, Tanriver Y, Jiang S, et al. Conferring indirect allospecificity on CD41CD251 Tregs by TCR gene transfer favors transplantation tolerance in mice. J Clin Invest. 2008;118(11): 3619-3628.
20. Pilat N, Wekerle T. Transplantation tolerance through mixed chimerism. Nat Rev Nephrol. 2010; 6(10):594-605.
21. Adeegbe D, Bayer AL, Levy RB, Malek TR. Cutting edge: allogeneic CD41CD251Foxp31 T regulatory cells suppress autoimmunity while establishing transplantation tolerance. J Immunol. 2006;176(12):7149-7153.
22. Lahl K, Loddenkemper C, Drouin C, et al. Selective depletion of Foxp31 regulatory T cells induces a scurfy-like disease. J Exp Med. 2007; 204(1):57-63.
23. Luther SA, Acha-Orbea H. Mouse mammary tumor virus: immunological interplays between virus and host. Adv Immunol. 1997;65:139-243.
24. Le Moine A, Flamand V, Demoor FX, et al. Critical roles for IL-4, IL-5, and eosinophils in chronic skin allograft rejection. J Clin Invest. 1999;103(12): 1659-1667.
25. Hanash AM, Levy RB. Donor CD41CD251 T cells promote engraftment and tolerance following MHC-mismatched hematopoietic cell transplantation. Blood. 2005;105(4):1828-1836.
26. Kawai T, Cosimi AB, Spitzer TR, et al. HLA-mismatched renal transplantation without maintenance immunosuppression. N Engl J Med. 2008;358(4):353-361.
27. Porcheray F, Wong W, Saidman SL, et al. B-cell immunity in the context of T-cell tolerance after combined kidney and bone marrow transplantation in humans. Am J Transplant. 2009;9(9):2126-2135.
28. Sykes M. Mixed chimerism and transplant tolerance. Immunity. 2001;14(4):417-424.
29. Mayer CT, Berod L, Sparwasser T. Layers of dendritic cell-mediated T cell tolerance, their regulation and the prevention of autoimmunity. Front Immunol. 2012;3:183.
30. Kendal AR, Waldmann H. Infectious tolerance: therapeutic potential. Curr Opin Immunol. 2010; 22(5):560-565.
31. Cobbold SP, Adams E, Nolan KF, Regateiro FS, Waldmann H. Connecting the mechanisms of T-cell regulation: dendritic cells as the missing link. Immunol Rev. 2010;236:203-218.
32. Qin S, Cobbold SP, Pope H, Elliott J, Kioussis D, Davies J, Waldmann H. “Infectious” transplantation tolerance. Science. 1993; 259(5097):974-977.
33. Chen ZK, Cobbold SP, Waldmann H, Metcalfe S. Amplification of natural regulatory immune mechanisms for transplantation tolerance. Transplantation. 1996;62(9):1200-1206.
34. Graca L, Thompson S, Lin CY, Adams E, Cobbold SP, Waldmann H. Both CD4(1)CD25(1) and CD4(1)CD25(-) regulatory cells mediate dominant transplantation tolerance. J Immunol. 2002;168(11):5558-5565.
35. Kendal AR, Chen Y, Regateiro FS, et al. Sustained suppression by Foxp31 regulatory T cells is vital for infectious transplantation tolerance. J Exp Med. 2011;208(10):2043-2053.
36. Hancock WW, Buelow R, Sayegh MH, Turka LA. Antibody-induced transplant arteriosclerosis is prevented by graft expression of anti-oxidant and anti-apoptotic genes. Nat Med. 1998;4(12): 1392-1396.
37. Andersson J, Tran DQ, Pesu M, Davidson TS, Ramsey H, O’Shea JJ, Shevach EM. CD41 FoxP31 regulatory T cells confer infectious tolerance in a TGF-beta-dependent manner. J Exp Med. 2008;205(9): 1975-1981.
38. Jonuleit H, Schmitt E, Kakirman H, Stassen M, Knop J, Enk AH. Infectious tolerance: human CD25(1) regulatory T cells convey suppressor activity to conventional CD4(1) T helper cells. J Exp Med. 2002;196(2): 255-260.
39. Fallarino F, Grohmann U, You S, et al. The combined effects of tryptophan starvation and tryptophan catabolites down-regulate T cell receptor zeta-chain and induce a regulatory phenotype in naive T cells. J Immunol. 2006; 176(11):6752-6761.
40. Cobbold SP, Adams E, Farquhar CA, et al. Infectious tolerance via the consumption of essential amino acids and mTOR signaling. Proc Natl Acad Sci USA. 2009;106(29): 12055-12060.
41. Leslie M. Immunology. Regulatory T cells get their chance to shine. Science. 2011;332(6033): 1020-1021.